These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29019223)
1. [Expression of pituitary tumor-transforming gene 1 during the development of androgen-independent prostate cancer]. Cao XL; Song XM; Yu WC; Chen YQ; Wei YY; Liu YL; Lu KQ Zhonghua Nan Ke Xue; 2016 Aug; 22(8):686-691. PubMed ID: 29019223 [TBL] [Abstract][Full Text] [Related]
2. [Downregulation of PTTG1 expression inhibits the proliferation and invasiveness and promotes the apoptosis of human prostate cancer LNCaP-AI cells]. Cao XL; Wei YY; Song XM; Lu KQ; Yu WC; Chen YQ; Liu YL; Gao JP Zhonghua Nan Ke Xue; 2017 Jul; 23(7):589-597. PubMed ID: 29723450 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression. Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516 [TBL] [Abstract][Full Text] [Related]
4. [Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer]. Xin DQ; Zhu XH; Lai YQ; You R; Na YQ; Guo YL; Mao ZB Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):638-40. PubMed ID: 16378119 [TBL] [Abstract][Full Text] [Related]
5. [Down-regulated PTTG1 expression promotes the senescence of human prostate cancer LNCaP-AI]. Wei YY; Song XM; Xiong ZH; Lu KQ; Zheng L; Cao XL Zhonghua Nan Ke Xue; 2019 Mar; 25(3):216-222. PubMed ID: 32216239 [TBL] [Abstract][Full Text] [Related]
6. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1. Huang S; Liao Q; Li W; Deng G; Jia M; Fang Q; Ji H; Meng M Bull Cancer; 2021 Apr; 108(4):359-368. PubMed ID: 33743960 [TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers. Xu B; Tang G; Xiao C; Wang L; Yang Q; Sun Y Int J Clin Exp Pathol; 2014; 7(6):2883-93. PubMed ID: 25031707 [TBL] [Abstract][Full Text] [Related]
8. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2. Zheng C; Yinghao S; Li J Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968 [TBL] [Abstract][Full Text] [Related]
9. PTTG1, A novel androgen responsive gene is required for androgen-induced prostate cancer cell growth and invasion. Zhang Z; Jin B; Jin Y; Huang S; Niu X; Mao Z; Xin D Exp Cell Res; 2017 Jan; 350(1):1-8. PubMed ID: 27756608 [TBL] [Abstract][Full Text] [Related]
10. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer]. Gan L; Yin ZF; Li M Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899 [TBL] [Abstract][Full Text] [Related]
11. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells. Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625 [TBL] [Abstract][Full Text] [Related]
12. Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1. Zhang Y; Chen B; Xu N; Xu P; Lin W; Liu C; Huang P Int J Nanomedicine; 2021; 16():315-327. PubMed ID: 33469288 [TBL] [Abstract][Full Text] [Related]
13. Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells. Xu S; Wu X; Tao Z; Li H; Fan C; Chen S; Guo J; Ning Y; Hu X Genes Genomics; 2020 Mar; 42(3):299-307. PubMed ID: 31872382 [TBL] [Abstract][Full Text] [Related]
14. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells. Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697 [TBL] [Abstract][Full Text] [Related]
15. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression. Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690 [TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation therapy has no effect on Pim-1 expression in a mouse model of prostate cancer. Wang J; Li G; Li B; Song H; Shang Z; Jiang N; Niu Y Oncol Lett; 2017 Jun; 13(6):4364-4370. PubMed ID: 28599438 [TBL] [Abstract][Full Text] [Related]
17. Gene microarray assessment of multiple genes and signal pathways involved in androgen-dependent prostate cancer becoming androgen independent. Liu JB; Dai CM; Su XY; Cao L; Qin R; Kong QB Asian Pac J Cancer Prev; 2014; 15(22):9791-5. PubMed ID: 25520106 [TBL] [Abstract][Full Text] [Related]
18. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells]. Wang HF; Liu WJ; Jin J; Zhou LQ; Liang LL; Wang Y; Guo YL Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):490-5. PubMed ID: 21844951 [TBL] [Abstract][Full Text] [Related]
19. [Screening of membrane antigen differentially expressed in androgen-dependent prostate cancer and androgen-independent prostate cancer]. Zhang X; Tang Z; Qi L; Chen H; Luo Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):817-23. PubMed ID: 22954909 [TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells. Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]